<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url><loc>https://nuvectis.irinbox.com/nuvectis/</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/leadership</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/pipeline</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/publications</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/trials</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/presentations</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/stock-info</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/historical-data</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/sec-filings</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/email-alerts</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/contact</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/governance-documents</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/disclaimer</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/terms</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/privacy</loc></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20261009-nuvectis-pharma-to-participate-in-the-maxim-growth-summit-20</loc><lastmod>2026-10-09</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260924-nuvectis-announces-nxp200-granted-breakthrough-therapy-desig</loc><lastmod>2026-09-24</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260903-nuvectis-pharma-to-participate-in-upcoming-investor-conferen</loc><lastmod>2026-09-03</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260804-nuvectis-pharma-reports-second-quarter-2026-financial-result</loc><lastmod>2026-08-04</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260723-correction-title-correction-nuvectis-announces-marketing-app</loc><lastmod>2026-07-23</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260723-ciprocopan-nxp100-receives-marketing-approval-in-china-for-t</loc><lastmod>2026-07-23</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260630-nuvectis-pharma-announces-pricing-of-100-million-public-offe</loc><lastmod>2026-06-30</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260629-nuvectis-pharma-announces-proposed-public-offering-of-common</loc><lastmod>2026-06-29</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260622-nuvectis-announces-strategic-portfolio-expansion-via-license</loc><lastmod>2026-06-22</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260514-nuvectis-pharma-inc-to-participate-in-the-hc-wainwright-4th</loc><lastmod>2026-05-14</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260505-nuvectis-pharma-inc-reports-first-quarter-2026-financial-res</loc><lastmod>2026-05-05</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260331-nuvectis-pharma-announces-upcoming-presentations-for-nxp900</loc><lastmod>2026-03-31</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20260211-nuvectis-pharma-inc-reports-2025-financial-results-and-busin</loc><lastmod>2026-02-11</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20251217-nuvectis-pharma-announces-the-initiation-of-the-phase-1b-stu</loc><lastmod>2025-12-17</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20251125-nuvectis-pharma-to-host-a-virtual-key-opinion-leader-meeting</loc><lastmod>2025-11-25</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20251104-correction-nuvectis-pharma-inc-reports-third-quarter-2025-fi</loc><lastmod>2025-11-04</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20251104-nuvectis-pharma-inc-reports-third-quarter-2025-financial-res</loc><lastmod>2025-11-04</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20251027-nuvectis-pharma-provides-poster-presentation-highlights-for</loc><lastmod>2025-10-27</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20251016-nuvectis-pharma-announces-upcoming-presentations-for-nxp900</loc><lastmod>2025-10-16</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250925-nuvectis-pharma-appoints-biotech-executive-juan-sanchez-md-t</loc><lastmod>2025-09-25</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250904-nuvectis-pharma-to-participate-at-the-hc-wainwright-27th-ann</loc><lastmod>2025-09-04</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250811-nuvectis-pharma-announces-the-initiation-of-the-phase-1b-pro</loc><lastmod>2025-08-11</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250805-nuvectis-pharma-inc-reports-second-quarter-2025-financial-re</loc><lastmod>2025-08-05</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250731-nuvectis-pharma-provides-final-clinical-data-update-from-the</loc><lastmod>2025-07-31</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250708-nuvectis-pharma-announces-successful-completion-of-a-drug-dr</loc><lastmod>2025-07-08</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250516-nuvectis-pharma-to-present-at-the-hc-wainwright-bioconnect-i</loc><lastmod>2025-05-16</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250506-nuvectis-pharma-inc-reports-first-quarter-2025-financial-res</loc><lastmod>2025-05-06</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250429-nuvectis-pharma-provides-poster-presentation-highlights-for</loc><lastmod>2025-04-29</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250326-nuvectis-pharma-announces-upcoming-presentations-for-nxp900</loc><lastmod>2025-03-26</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250314-nuvectis-pharma-to-participate-in-the-37th-annual-roth-confe</loc><lastmod>2025-03-14</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250304-nuvectis-pharma-announces-a-new-publication-of-a-research-st</loc><lastmod>2025-03-04</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250225-nuvectis-pharma-inc-reports-2024-financial-results-and-busin</loc><lastmod>2025-02-25</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250207-nuvectis-pharma-announces-closing-of-155-million-public-offe</loc><lastmod>2025-02-07</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250205-nuvectis-pharma-announces-pricing-of-135-million-public-offe</loc><lastmod>2025-02-05</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20250204-nuvectis-pharma-announces-proposed-public-offering-of-common</loc><lastmod>2025-02-04</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20241210-nuvectis-pharma-to-present-at-the-2024-ladenburg-virtual-onc</loc><lastmod>2024-12-10</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20241114-nuvectis-pharma-reports-encouraging-nxp800-interim-data-supp</loc><lastmod>2024-11-14</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20241105-nuvectis-pharma-inc-reports-third-quarter-2024-financial-res</loc><lastmod>2024-11-05</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20241023-nuvectis-pharma-announces-upcoming-presentations-for-nxp900</loc><lastmod>2024-10-23</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20241007-nuvectis-pharma-to-participate-in-the-3rd-annual-roth-health</loc><lastmod>2024-10-07</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240905-nuvectis-pharma-to-present-at-the-hc-wainwright-26th-annual</loc><lastmod>2024-09-05</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240829-nuvectis-pharma-announces-orphan-drug-designation-granted-by</loc><lastmod>2024-08-29</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240806-nuvectis-pharma-inc-reports-second-quarter-2024-financial-re</loc><lastmod>2024-08-06</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240516-nuvectis-pharma-inc-to-present-at-the-hc-wainwright-bioconne</loc><lastmod>2024-05-16</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240507-nuvectis-pharma-inc-reports-first-quarter-2024-financial-res</loc><lastmod>2024-05-07</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240408-nuvectis-pharmas-nxp900-demonstrates-robust-activity-in-non</loc><lastmod>2024-04-08</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240319-nuvectis-pharma-announces-upcoming-presentations-at-the-2024</loc><lastmod>2024-03-19</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240315-nuvectis-pharma-to-present-at-the-36th-annual-roth-conferenc</loc><lastmod>2024-03-15</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240314-nuvectis-pharma-announces-encouraging-preliminary-data-from</loc><lastmod>2024-03-14</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240305-nuvectis-pharma-inc-reports-fiscal-year-2023-financial-resul</loc><lastmod>2024-03-05</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240209-correction-nuvectis-pharma-announces-participation-at-upcomi</loc><lastmod>2024-02-09</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240209-nuvectis-pharma-announces-participation-at-upcoming-investor</loc><lastmod>2024-02-09</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20240103-nuvectis-pharma-to-present-at-the-42nd-annual-jp-morgan-heal</loc><lastmod>2024-01-03</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20231218-nuvectis-pharma-inc-announces-a-collaboration-with-mayo-clin</loc><lastmod>2023-12-18</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20231108-nuvectis-pharma-inc-reports-third-quarter-2023-financial-res</loc><lastmod>2023-11-08</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20231024-nuvectis-pharma-announces-upcoming-poster-presentation-for-n</loc><lastmod>2023-10-24</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230925-nuvectis-pharma-announces-updated-date-and-time-for-the-2023</loc><lastmod>2023-09-25</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230921-nuvectis-pharma-announces-upcoming-presentations-for-nxp800</loc><lastmod>2023-09-21</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230912-nuvectis-pharma-announces-initiation-of-the-nxp900-phase-1a</loc><lastmod>2023-09-12</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230906-nuvectis-pharma-to-host-kol-event-to-discuss-its-two-precisi</loc><lastmod>2023-09-06</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230901-nuvectis-pharma-announces-participation-at-upcoming-investor</loc><lastmod>2023-09-01</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230817-nuvectis-pharma-announces-orphan-drug-designation-granted-by</loc><lastmod>2023-08-17</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230809-nuvectis-pharma-inc-reports-second-quarter-2023-financial-re</loc><lastmod>2023-08-09</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230620-nuvectis-pharma-set-to-join-the-russell-2000-and-russell-300</loc><lastmod>2023-06-20</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230515-nuvectis-pharma-announces-fda-clearance-of-nxp900-ind</loc><lastmod>2023-05-15</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230510-nuvectis-pharma-inc-reports-first-quarter-2023-financial-res</loc><lastmod>2023-05-10</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230427-correction-nuvectis-pharma-inc-to-present-at-the-hc-wainwrig</loc><lastmod>2023-04-27</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230427-nuvectis-pharma-inc-to-present-at-the-hc-wainwright-bioconne</loc><lastmod>2023-04-27</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230418-nuvectis-pharma-recaps-poster-presentation-highlights-for-nx</loc><lastmod>2023-04-18</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230410-nuvectis-pharma-announces-initiation-of-the-phase-1b-study-f</loc><lastmod>2023-04-10</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230317-nuvectis-pharma-announces-upcoming-presentations-at-the-2023</loc><lastmod>2023-03-17</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230310-nuvectis-pharma-to-participate-in-a-fireside-chat-at-the-35t</loc><lastmod>2023-03-10</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230307-nuvectis-pharma-inc-reports-fiscal-year-2022-financial-resul</loc><lastmod>2023-03-07</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230223-nuvectis-pharma-recaps-poster-presentation-highlights-for-nx</loc><lastmod>2023-02-23</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230209-nuvectis-pharma-announces-a-publication-in-the-journal-of-ex</loc><lastmod>2023-02-09</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20230104-nuvectis-pharma-announces-collaboration-with-engot-and-gog-f</loc><lastmod>2023-01-04</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20221201-fda-grants-fast-track-designation-to-nuvectis-pharmas-nxp800</loc><lastmod>2022-12-01</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20221108-nuvectis-pharma-inc-reports-third-quarter-2022-financial-res</loc><lastmod>2022-11-08</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20221018-nuvectis-phrama-announces-two-upcoming-poster-presentations</loc><lastmod>2022-10-18</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20221003-nuvectis-pharma-inc-to-present-at-the-roth-inaugural-healthc</loc><lastmod>2022-10-03</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220928-nuvectis-pharma-announces-formation-of-a-scientific-advisory</loc><lastmod>2022-09-28</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220913-nuvectis-pharma-announces-positive-data-for-nxp800-in-a-prec</loc><lastmod>2022-09-13</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220907-nuvectis-pharma-inc-to-present-at-upcoming-investment-confer</loc><lastmod>2022-09-07</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220805-nuvectis-pharma-inc-reports-second-quarter-2022-financial-re</loc><lastmod>2022-08-05</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220801-nuvectis-pharma-announces-closing-of-approximately-159-milli</loc><lastmod>2022-08-01</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220727-nuvectis-pharma-inc-announces-approximately-159-million-priv</loc><lastmod>2022-07-27</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220621-nuvectis-pharma-announces-fda-clearance-of-ind-for-nxp800</loc><lastmod>2022-06-21</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220613-nuvectis-pharma-announces-positive-data-for-nxp900-in-a-prec</loc><lastmod>2022-06-13</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220520-nuvectis-pharma-to-present-in-the-hc-wainwright-global-inves</loc><lastmod>2022-05-20</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220510-nuvectis-pharma-inc-reports-first-quarter-2022-financial-res</loc><lastmod>2022-05-10</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220413-nuvectis-pharma-recaps-poster-presentation-highlights-for-nx</loc><lastmod>2022-04-13</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220411-nuvectis-pharma-recaps-oral-presentation-highlights-for-nxp8</loc><lastmod>2022-04-11</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220322-nuvectis-pharma-inc-reports-fiscal-year-2021-financial-resul</loc><lastmod>2022-03-22</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220310-nuvectis-announces-upcoming-oral-and-poster-presentations-at</loc><lastmod>2022-03-10</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220309-update-nuvectis-pharma-to-participate-in-a-fireside-chat-at</loc><lastmod>2022-03-09</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220222-nuvectis-announces-positive-data-for-nxp900-in-triple-negati</loc><lastmod>2022-02-22</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220208-nuvectis-pharma-announces-closing-of-16000000-upsized-initia</loc><lastmod>2022-02-08</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20220204-nuvectis-pharma-inc-announces-pricing-of-16000000-upsized-in</loc><lastmod>2022-02-04</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20211231-nuvectis-pharma-initiates-phase-1-clinical-trial-of-nxp800</loc><lastmod>2021-12-31</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20210914-nuvectis-pharma-in-licenses-exclusive-worldwide-rights-to-a</loc><lastmod>2021-09-14</lastmod></url>
  <url><loc>https://nuvectis.irinbox.com/nuvectis/press-releases/nvct-20210826-nuvectis-pharma-raises-15-million-and-in-licenses-exclusive</loc><lastmod>2021-08-26</lastmod></url>
</urlset>
